{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:48Z","timestamp":1786985448479,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002966","name":"Cumhuriyet University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bpc.2021.106564","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T03:14:20Z","timestamp":1613877260000},"page":"106564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods"],"prefix":"10.1016","volume":"272","author":[{"given":"Alireza","family":"Poustforoosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Hashemipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"T\u00fcz\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Pardakhty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnaz","family":"Mehrabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hadi","family":"Nematollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bpc.2021.106564_bb0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.arcmed.2020.06.007","article-title":"Laboratory findings of COVID-19 infection are conflicting in different age groups and pregnant women: a literature review","volume":"51","author":"Vakili","year":"2020","journal-title":"Arch. Med. Res."},{"issue":"May","key":"10.1016\/j.bpc.2021.106564_bb0010","doi-asserted-by":"crossref","first-page":"100345","DOI":"10.1016\/j.imu.2020.100345","article-title":"Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: a computational study","volume":"19","author":"Peele","year":"2020","journal-title":"Informat. Med. Unlocked"},{"issue":"5","key":"10.1016\/j.bpc.2021.106564_bb0015","first-page":"554","article-title":"COVID-19 spike-host cell receptor GRP78 binding site prediction","volume":"80","author":"Ibrahim","year":"2020","journal-title":"J. Inf. Secur."},{"issue":"6","key":"10.1016\/j.bpc.2021.106564_bb0020","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/jmv.24736","article-title":"Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses","volume":"89","author":"Elfiky","year":"2017","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bpc.2021.106564_bb0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health \u2014 The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bpc.2021.106564_bb0030","doi-asserted-by":"crossref","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bpc.2021.106564_bb0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2217\/fvl-2017-0081","article-title":"Zika virus: novel guanosine derivatives revealed strong binding and possible inhibition of the polymerase","volume":"12","author":"Elfiky","year":"2017","journal-title":"Futur. Virol."},{"issue":"5","key":"10.1016\/j.bpc.2021.106564_bb0040","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00044-016-1533-y","article-title":"IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study","volume":"25","author":"Elfiky","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bpc.2021.106564_bb0045","doi-asserted-by":"crossref","first-page":"116958","DOI":"10.1016\/j.lfs.2019.116958","article-title":"Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV","volume":"238","author":"Elfiky","year":"2019","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bpc.2021.106564_bb0050","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/jmv.24678","article-title":"Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials","volume":"88","author":"Elfiky","year":"2016","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.bpc.2021.106564_bb0055","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","article-title":"Drug repurposing for viral infectious diseases: how far are we?","volume":"26","author":"Mercorelli","year":"2018","journal-title":"Trends Microbiol."},{"issue":"6","key":"10.1016\/j.bpc.2021.106564_bb0060","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/QCO.0000000000000212","article-title":"The future of antivirals: broad-spectrum inhibitors","volume":"28","author":"Debing","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.bpc.2021.106564_bb0065","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0959-440X(98)80089-4","article-title":"The mechanism of action of T7 DNA polymerase","volume":"8","author":"Doubli\u00e9","year":"1998","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bpc.2021.106564_bb0070","doi-asserted-by":"crossref","first-page":"117477","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bpc.2021.106564_bb0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/1062936X.2018.1454981","article-title":"Molecular docking revealed the binding of nucleotide\/side inhibitors to Zika viral polymerase solved structures","volume":"29","author":"Elfiky","year":"2018","journal-title":"SAR QSAR Environ. Res."},{"issue":"6492","key":"10.1016\/j.bpc.2021.106564_bb0080","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bpc.2021.106564_bb0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","article-title":"Structural basis for RNA replication by the SARS-CoV-2 polymerase","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bpc.2021.106564_bb0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses-drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.bpc.2021.106564_bb0095","first-page":"606","article-title":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus","volume":"67","author":"Chan","year":"2013","journal-title":"J. Inf. Secur."},{"issue":"5","key":"10.1016\/j.bpc.2021.106564_bb0100","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.bpc.2021.106564_bb0105","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.bpc.2021.106564_bb0110","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"De Wilde","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bpc.2021.106564_bb0115","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1473-3099(14)70920-X","article-title":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study","volume":"14","author":"Omrani","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.bpc.2021.106564_bb0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.matt.2020.10.032","article-title":"Comparative analysis of nanomechanical features of coronavirus spike proteins and correlation with lethality and infection rate","volume":"4","author":"Hu","year":"2021","journal-title":"Matter"},{"issue":"28","key":"10.1016\/j.bpc.2021.106564_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb8097","article-title":"Structure-based drug designing and immunoinformatics approach for SARS-CoV-2","volume":"6","author":"Panda","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bpc.2021.106564_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acsabm.0c01004","article-title":"Electrochemical SARS-CoV-2 sensing at point-of-care and artificial intelligence for intelligent COVID-19 management","volume":"3","author":"Kaushik","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bpc.2021.106564_bb0135","doi-asserted-by":"crossref","first-page":"100011","DOI":"10.1016\/j.crgsc.2020.100011","article-title":"Tackling COVID-19 pandemic through nanocoatings: confront and exactitude","volume":"3","author":"Rai","year":"2020","journal-title":"Curr. Res. Green Sustain. Chem."},{"key":"10.1016\/j.bpc.2021.106564_bb0140","article-title":"Targeted delivery of CRISPR\/Cas13 as a promising therapeutic approach to treat SARS-CoV-2","volume":"21","author":"Goudarzi","year":"2020","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"9","key":"10.1016\/j.bpc.2021.106564_bb0145","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jiph.2020.06.016","article-title":"In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing","volume":"13","author":"Kumar","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.bpc.2021.106564_bb0150","first-page":"1","article-title":"Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2","author":"Yadav","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bpc.2021.106564_bb0155","doi-asserted-by":"crossref","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS- CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"El","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bpc.2021.106564_bb0160","series-title":"Small-Molecule Drug Discovery Suite 2020\u20134","author":"Schrodinger","year":"2020"},{"key":"10.1016\/j.bpc.2021.106564_bb0165","series-title":"Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY 2016; Impact, Schr\u00f6dinger, LLC, New York, NY 2016","author":"Schr\u00f6dinger Release 2020-4","year":"2020"},{"issue":"8","key":"10.1016\/j.bpc.2021.106564_bb0170","doi-asserted-by":"crossref","first-page":"572","DOI":"10.6026\/97320630015572","article-title":"Homology modeling and molecular dynamics dimulation study of \u03b2 carbonic anhydrase of Ascaris lumbricoides","volume":"15","author":"Yadav","year":"2019","journal-title":"Bioinformation"},{"issue":"2","key":"10.1016\/j.bpc.2021.106564_bb0175","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2021.106564_bb0180","series-title":"LigPrep","author":"Schr\u00f6dinger Release 2020-4","year":"2020"},{"issue":"1","key":"10.1016\/j.bpc.2021.106564_bb0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/prot.22564","article-title":"Present and future chanllenges and limitations in protein-protein clocking","volume":"78","author":"Pons","year":"2010","journal-title":"Proteins Struct. Funct. Bioinforma."},{"issue":"9","key":"10.1016\/j.bpc.2021.106564_bb0190","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.str.2020.06.006","article-title":"Performance and its limits in rigid body protein-protein docking","volume":"28","author":"Desta","year":"2020","journal-title":"Structure"},{"issue":"9","key":"10.1016\/j.bpc.2021.106564_bb0195","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.bmc.2005.12.032","article-title":"New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies","volume":"14","author":"Farid","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bpc.2021.106564_bb0200","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bpc.2021.106564_bb0205","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bpc.2021.106564_bb0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins Struct. Funct. Genet."},{"key":"10.1016\/j.bpc.2021.106564_bb0215","first-page":"243824","article-title":"Development of putative isospecific inhibitors for HDAC6 using random forest, QM-polarized docking, induced-fit docking, and quantum mechanics","author":"Ireoluwa Yinka","year":"2020","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.bpc.2021.106564_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s42452-020-2333-z","article-title":"Theoretical study of the adiponectin receptors: binding site characterization and molecular dynamics of possible ligands for drug design","volume":"2","author":"Muratore","year":"2020","journal-title":"SN Appl. Sci."},{"key":"10.1016\/j.bpc.2021.106564_bb0225","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejmech.2019.02.046","article-title":"Challenges and current status of computational methods for docking small molecules to nucleic acids","volume":"168","author":"Luo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bpc.2021.106564_bb0230","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/bib\/bbp023","article-title":"Recent advances in computer-aided drug design","volume":"10","author":"Song","year":"2009","journal-title":"Brief. Bioinform."},{"issue":"9","key":"10.1016\/j.bpc.2021.106564_bb0235","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery","volume":"38","author":"Macalino","year":"2015","journal-title":"Arch. Pharm. Res."},{"issue":"5665","key":"10.1016\/j.bpc.2021.106564_bb0240","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.1096361","article-title":"The many roles of computation in drug discovery","volume":"303","author":"Jorgensen","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bpc.2021.106564_bb0245","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cbi.2006.12.006","article-title":"Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach","volume":"171","author":"Kapetanovic","year":"2008","journal-title":"Chem. Biol. Interact."},{"issue":"18","key":"10.1016\/j.bpc.2021.106564_bb0250","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: Shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bpc.2021.106564_bb0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nbt1273","article-title":"Structure-based maximal affinity model predicts small-molecule druggability","volume":"25","author":"Cheng","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.bpc.2021.106564_bb0260","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1021\/ci900388a","article-title":"Molecular docking of carbohydrate ligands to antibodies: structural validation against crystal structures","volume":"49","author":"Agostillo","year":"2009","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.bpc.2021.106564_bb0265","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/hon.2173","article-title":"Conventional and high-dose daunorubicin and idarubicin in acute myeloid leukaemia remission induction treatment: a mixed treatment comparison meta-analysis of 7258 patients","volume":"33","author":"Sekine","year":"2015","journal-title":"Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bpc.2021.106564_bb0270","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/21505594.2020.1770493","article-title":"Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus","volume":"11","author":"She","year":"2020","journal-title":"Virulence"},{"issue":"5","key":"10.1016\/j.bpc.2021.106564_bb0275","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1099\/jgv.0.000431","article-title":"Idarubicin is a broad-spectrum enterovirus replication inhibitor that selectively targets the virus internal ribosomal entry site","volume":"97","author":"Hou","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bpc.2021.106564_bb0280","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijbiomac.2013.05.027","article-title":"Structural investigation of idarubicin-DNA interaction: spectroscopic and molecular docking study","volume":"60","author":"Charak","year":"2013","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462221000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462221000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:55:33Z","timestamp":1759564533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462221000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":56,"alternative-id":["S0301462221000247"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2021.106564","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2021.106564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106564"}}